Alpha Healthcare Acquisition Corp III

Company Profile

Alpha Healthcare Acquisition Corp III had its IPO on 2021-09-23 under the ticker symbol ALPA.

The company operates in the Financial Services sector and Shell Companies industry. Alpha Healthcare Acquisition Corp III has a staff strength of 0 employees.

Stock update

Shares of Alpha Healthcare Acquisition Corp III opened at $10.25 at the start of the last trading session i.e. 2023-03-31.

The stocks traded within a range of $10.15 - $10.25, and closed at $10.15.

This is a -0.49% slip from the previous day's closing price.

A total volume of 18,137 shares were traded at the close of the day’s session.

In the last one week, shares of Alpha Healthcare Acquisition Corp III have increased by +0.3%.

Alpha Healthcare Acquisition Corp III's Key Ratios

Alpha Healthcare Acquisition Corp III has a market cap of $194.79 million, indicating a price to book ratio of 1.3051 and a price to sales ratio of 0.

In the last 12-months Alpha Healthcare Acquisition Corp III’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Alpha Healthcare Acquisition Corp III's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Alpha Healthcare Acquisition Corp III’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q3, Alpha Healthcare Acquisition Corp III’s quarterly earnings growth was a positive 1380.4% while revenue growth was a positive 0%.

Alpha Healthcare Acquisition Corp III’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.09 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alpha Healthcare Acquisition Corp III’s profitability.

Alpha Healthcare Acquisition Corp III stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -417.0476. Its price to sales ratio in the trailing 12-months stood at 0.

Alpha Healthcare Acquisition Corp III stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$155.89 million

Total Liabilities

$830792.00

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Alpha Healthcare Acquisition Corp III ended 2023 with $155.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $155.89 million while shareholder equity stood at $-5371834.00.

Alpha Healthcare Acquisition Corp III ended 2023 with $0 in deferred long-term liabilities, $830792.00 in other current liabilities, 155024990.00 in common stock, $-5372266.00 in retained earnings and $0 in goodwill. Its cash balance stood at $376832.00 and cash and short-term investments were $376832.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

Alpha Healthcare Acquisition Corp III’s total current assets stands at $529070.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $816092.00 and inventory worth $0.

In 2023, Alpha Healthcare Acquisition Corp III's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Alpha Healthcare Acquisition Corp III paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$10.15

52-Week High

$10.1

52-Week Low

$9.62

Analyst Target Price

$

Alpha Healthcare Acquisition Corp III stock is currently trading at $10.15 per share. It touched a 52-week high of $10.1 and a 52-week low of $10.1. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $10.08 and 200-day moving average was $9.86 The short ratio stood at 0.06 indicating a short percent outstanding of 0%.

Around 2427.1% of the company’s stock are held by insiders while 8125.4% are held by institutions.